Sanofi (France pharma buyer/processor)
EMEA
Paris
,
France
Multinational
FOUNDED
1973
HEADCOUNT
10000+
FUNDING
Public
Keywords:
therapeutics, vaccines, antibodies, CDMO
BUSINESS
Sanofi is a global pharmaceutical multinational developing and marketing prescription medicines, vaccines and consumer healthcare products. Its historical fine-chemicals and fermentation activity, including shikimic acid produced via E. coli fermentation at Saint-Aubin-les-Elbeuf (Tamiflu starting material), was carved out in 2022 into EUROAPI, now a separate listed company.
BIOTECH INVOLVEMENT
Peripheral; Sanofi is a pharmaceutical company rather than an in-scope industrial-biotech producer. Its prior microbial-fermentation API/fine-chemicals operations (shikimic acid, vitamin B12) were divested into EUROAPI in 2022, which now operates the Saint-Aubin-les-Elbeuf fermentation site. Sanofi retains biologics/vaccine manufacturing but not industrial-biotech commodity fermentation.
TECHNOLOGY PLATFORM
vaccine and biologics manufacturing
PRIMARY PRODUCTS